Harvard researcher honored with 2026 Breakthrough Prize for gene-editing research enabling FDA-approved cures for sickle cell disease and beta thalassemia in Boston.
← News
Medicine Breakthroughs Medicine Breakthroughs Health
Four Boston-area researchers honored with 2026 Breakthrough Prize
2026 Breakthrough Prize Award
Harvard Medical School, Dana-Farber, Boston Children'S Hospi Affiliation
First FDA-Approved Gene-Editing Cure For Sickle Cell And Bet Medical breakthrough
Millions Worldwide patients impacted
2 Blood Disorders FDA-approved cures